📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Axonal loss influences the response to rituximab treatment in neuropathy associated with IgM monoclonal gammopathy with anti-myelin-associated glycoprotein antibody. (2015)

First Author: Kawagashira Y

Attributed to: MICA: MRC Centre for Neuromuscular Diseases funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jns.2014.11.006

PubMed Identifier: 25467141

Publication URI: http://europepmc.org/abstract/MED/25467141

Type: Journal Article/Review

Volume: 348

Parent Publication: Journal of the neurological sciences

Issue: 1-2

ISSN: 0022-510X